One Biosciences

Paris, France

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

$17.4M raised

Jul 2025

Series A

Biotechnology Life Science Therapeutics

Top Investors

Redmile GroupKima VenturesSofinnova PartnersPolytechnique VenturesHome Biosciences

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about One Biosciences

How much funding has One Biosciences raised?

One Biosciences has raised $17.4M in total funding. The most recent round was Series A. The last funding was announced in July 2025.

Who are One Biosciences's investors?

One Biosciences's investors include Redmile Group, Kima Ventures, Sofinnova Partners, Polytechnique Ventures, Home Biosciences.

Where is One Biosciences headquartered?

One Biosciences is headquartered in Paris, France.

What does One Biosciences do?

One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.

What stage is One Biosciences at?

One Biosciences is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 17, 2025.

MLA

"One Biosciences — Funding & Investors." VCBacked, July 17, 2025, https://www.vcbacked.co/company/one-biosciences. Accessed June 4, 2026.

APA

VCBacked. (2025). One Biosciences — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/one-biosciences

Wikipedia (cite web)

{{cite web |title=One Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/one-biosciences |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 17, 2025.

Similar Companies in Biotechnology